LD50=190 mg/kg (orally in mice). Prolonged apnoea, neuromuscular paralysis and cardiac arrest may occur.
Decamethonium is used in anesthesia to cause paralysis. It is a short acting depolarizing muscle relaxant. It is similar to acetylcholine and acts as a partial agonist of the nicotinic acetylcholine receptor.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Decamethonium. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Decamethonium. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Decamethonium. |
| Hydrocodone | Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Decamethonium. |
| Magnesium sulfate | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Decamethonium may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Decamethonium. |
| Mirtazapine | Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Decamethonium. |
| Orphenadrine | Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Decamethonium. |
| Pramipexole | Decamethonium may increase the sedative activities of Pramipexole. |
| Ropinirole | Decamethonium may increase the sedative activities of Ropinirole. |
| Rotigotine | Decamethonium may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Decamethonium. |
| Sodium oxybate | Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Decamethonium. |
| Thalidomide | Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Capreomycin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Capreomycin. |
| Botulinum toxin type B | The therapeutic efficacy of Decamethonium can be increased when used in combination with Botulinum toxin type B. |
| Botulinum toxin type A | The therapeutic efficacy of Decamethonium can be increased when used in combination with Botulinum toxin type A. |
| Cyclosporine | The therapeutic efficacy of Decamethonium can be increased when used in combination with Cyclosporine. |
| Doxycycline | The therapeutic efficacy of Decamethonium can be increased when used in combination with Doxycycline. |
| Lymecycline | The therapeutic efficacy of Decamethonium can be increased when used in combination with Lymecycline. |
| Piperacillin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Piperacillin. |
| Framycetin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Framycetin. |
| Clomocycline | The therapeutic efficacy of Decamethonium can be increased when used in combination with Clomocycline. |
| Quinine | The therapeutic efficacy of Decamethonium can be increased when used in combination with Quinine. |
| Vancomycin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Vancomycin. |
| Tigecycline | The therapeutic efficacy of Decamethonium can be increased when used in combination with Tigecycline. |
| Oxytetracycline | The therapeutic efficacy of Decamethonium can be increased when used in combination with Oxytetracycline. |
| Chloroquine | The therapeutic efficacy of Decamethonium can be increased when used in combination with Chloroquine. |
| Demeclocycline | The therapeutic efficacy of Decamethonium can be increased when used in combination with Demeclocycline. |
| Tobramycin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Tobramycin. |
| Tetracycline | The therapeutic efficacy of Decamethonium can be increased when used in combination with Tetracycline. |
| Gentamicin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Gentamicin. |
| Etacrynic acid | The therapeutic efficacy of Decamethonium can be increased when used in combination with Etacrynic acid. |
| Metacycline | The therapeutic efficacy of Decamethonium can be increased when used in combination with Metacycline. |
| Netilmicin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Netilmicin. |
| Neomycin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Neomycin. |
| Procainamide | The therapeutic efficacy of Decamethonium can be increased when used in combination with Procainamide. |
| Streptomycin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Streptomycin. |
| Colistimethate | The therapeutic efficacy of Decamethonium can be increased when used in combination with Colistimethate. |
| Kanamycin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Kanamycin. |
| Rolitetracycline | The therapeutic efficacy of Decamethonium can be increased when used in combination with Rolitetracycline. |
| Magnesium oxide | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium oxide. |
| Magnesium cation | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium cation. |
| Paromomycin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Paromomycin. |
| Lincomycin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Lincomycin. |
| Ribostamycin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Ribostamycin. |
| Geneticin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Geneticin. |
| Apramycin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Apramycin. |
| Gentamicin C1a | The therapeutic efficacy of Decamethonium can be increased when used in combination with Gentamicin C1a. |
| Neamine | The therapeutic efficacy of Decamethonium can be increased when used in combination with Neamine. |
| Arbekacin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Arbekacin. |
| Viomycin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Viomycin. |
| Puromycin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Puromycin. |
| Magnesium hydroxide | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium hydroxide. |
| Magnesium trisilicate | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium trisilicate. |
| Magnesium chloride | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium chloride. |
| Magnesium acetate tetrahydrate | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium acetate tetrahydrate. |
| Magnesium carbonate | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium carbonate. |
| Magnesium citrate | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium citrate. |
| Magnesium glycinate | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium glycinate. |
| Magnesium Aluminum Silicate | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium Aluminum Silicate. |
| Dihydrostreptomycin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Dihydrostreptomycin. |
| Hygromycin B | The therapeutic efficacy of Decamethonium can be increased when used in combination with Hygromycin B. |
| Sisomicin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Sisomicin. |
| Plazomicin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Plazomicin. |
| Magnesium silicate | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium silicate. |
| Penimepicycline | The therapeutic efficacy of Decamethonium can be increased when used in combination with Penimepicycline. |
| Magnesium aspartate | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium aspartate. |
| Isepamicin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Isepamicin. |
| Magnesium gluconate | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium gluconate. |
| Magnesium orotate | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium orotate. |
| Magnesium phosphate | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium phosphate. |
| Magnesium acetate | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium acetate. |
| Mecamylamine | The therapeutic efficacy of Decamethonium can be increased when used in combination with Mecamylamine. |
| Quinidine | The therapeutic efficacy of Decamethonium can be increased when used in combination with Quinidine. |
| Dantrolene | The therapeutic efficacy of Decamethonium can be increased when used in combination with Dantrolene. |
| Magnesium stearate | The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium stearate. |
| Colistin | The therapeutic efficacy of Decamethonium can be increased when used in combination with Colistin. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Decamethonium. |
| Dipyridamole | The therapeutic efficacy of Decamethonium can be decreased when used in combination with Dipyridamole. |
| Ephedrine | Decamethonium may increase the neuromuscular blocking activities of Ephedrine. |
| Bambuterol | Decamethonium may increase the neuromuscular blocking activities of Bambuterol. |
| Clevidipine | Decamethonium may increase the neuromuscular blocking activities of Clevidipine. |
| Sar9, Met (O2)11-Substance P | Decamethonium may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Mirabegron | Decamethonium may increase the neuromuscular blocking activities of Mirabegron. |
| Moxisylyte | Decamethonium may increase the neuromuscular blocking activities of Moxisylyte. |
| Propacetamol | Decamethonium may increase the neuromuscular blocking activities of Propacetamol. |
| Procaine | Decamethonium may increase the neuromuscular blocking activities of Procaine. |
| Cocaine | Decamethonium may increase the neuromuscular blocking activities of Cocaine. |
| Trimethaphan | Decamethonium may increase the neuromuscular blocking activities of Trimethaphan. |